Organization
Mounjaro
Mounjaro is a medication used to treat type 2 diabetes.
41 articles
Activity
Sat, May 23 Today
Surge in Online Searches and Policy Changes Highlight Growing GLP-1 Weight-Loss Drug Concerns
Following a Super Bowl commercial, online searches for GLP-1 weight-loss drugs have skyrocketed, raising safety concerns over unverified sales. Simultaneously, some US states are cutting Medicaid coverage, complicating access for low-income users.
· 49d ago
Eli Lilly’s Retatrutide Cuts Body Weight by 17%, Lowers HbA1C in Phase 3 Diabetes Trial
Eli Lilly's diabetes drug Retatrutide caused up to 17% body weight loss and nearly 2% HbA1C reduction in a Phase 3 trial. These results suggest a major advancement in diabetes treatment by addressing both blood sugar and obesity effectively.
· 77d ago